Acting for the Australian Government in four heavily fought and ground-breaking claims (valued together at more than A$750 million) brought by the Government against global pharmaceutical companies, arising from delays in competition for blockbuster medicines in the Australian market.
This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.